FindTrial
Sign In

A Real-world Study of Endostar Combined with Chemotherapy and Chemoradiotherapy in the Treatment of Non-Small Cell Lung Cancer and Esophageal Cancer

A Real-world Study of Endostar Combined with Chemotherapy and Chemoradiotherapy in the Treatment of Non-Small Cell Lung Cancer and Esophageal Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035129
Enrollment
Unknown
Registered
2020-08-01
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer and Esophageal Cancer

Interventions

case series:N/A

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with at least one hospitalization and Satisfy any one of the following: 1.NSCLC patients treated with stage III/IV chemotherapy at initial or subsequent treatment 2.Stage III non-operative chemoradiotherapy for NSCLC patients 3.EC (stage IVa) patients

Exclusion criteria

Exclusion criteria: Exclusion criteria (in accordance with any of the following) 1) Patients under 18 years old; 2) Patients with multiple carcinoma in situ.

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival;Disease Control Rate;—

Secondary

MeasureTime frame
Adverse Events;—

Countries

China

Contacts

Public ContactLvhua Wang

Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Hospital

wlhwq@yahoo.com+86 13601283715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026